Iseni Frédéric, Tournier Jean-Nicolas
Institut de recherche biomédicale des armées, Unité de virologie, Département Microbiologie et maladies infectieuses, 1 place général Valérie André, 91220 Brétigny-sur-Orge, France.
Institut de recherche biomédicale des armées, Unité Biothérapies anti-infectieuses et immunité, Département Microbiologie et maladies infectieuses, Brétigny-sur-Orge, France - Institut Pasteur, unité génomique virale et vaccination, CNRS UMR 3569, Paris, France - École du Val-de-Grâce, Paris, France.
Med Sci (Paris). 2020 Aug-Sep;36(8-9):797-802. doi: 10.1051/medsci/2020124. Epub 2020 Aug 5.
SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2, which emerged in China at the end of 2019, is responsible for a global health crisis resulting in the confinement of more than 3 billion people worldwide and the sharp decline of the world economy. In this context, a race against the clock is launched in order to develop a treatment to stop the pandemic as soon as possible. A study published in Nature by the Volker Thiel team reports the development of reverse genetics for SARS-CoV-2 allowing them to recreate the virus in just a few weeks. The perspectives of this work are very interesting since it will allow the genetic manipulation of the virus and thus the development of precious tools which will be useful to fight the infection. Even though this approach represents a technological leap that will improve our knowledge of the virus, it also carries the germ of possible misuse and the creation of the virus for malicious purposes. The advantages and disadvantages of recreating SARS-CoV-2 in this pandemic period are discussed in this mini-synthesis.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)于2019年底在中国出现,引发了一场全球健康危机,导致全球超过30亿人被隔离,世界经济急剧衰退。在此背景下,为尽快研发出阻止这一疫情大流行的治疗方法,一场争分夺秒的竞赛展开了。福尔克·蒂尔团队在《自然》杂志上发表的一项研究报告了SARS-CoV-2反向遗传学的进展,这使得他们能够在短短几周内重新制造出这种病毒。这项工作的前景非常有趣,因为它将使对该病毒进行基因操作成为可能,从而开发出对抗感染有用的宝贵工具。尽管这种方法代表了一项技术飞跃,将增进我们对该病毒的了解,但它也存在被滥用以及出于恶意目的制造病毒的隐患。本短文综述讨论了在这一疫情期间重新制造SARS-CoV-2的利弊。